San Francisco, CA - Uncountable, the AI platform for end-to-end product development, today announced a new customer relationship with Qnity, an independent electronics materials company focused on enabling advanced semiconductor and electronics manufacturing. Qnity has selected Uncountable to support the digital transformation of its R&D operations and centralize R&D data within a single, secure platform.
Using Uncountable’s platform, Qnity aims to enrich its data management, governance, and security processes. Uncountable’s platform will also improve tracking of lab processes from initial requests through execution and reporting, enabling greater collaboration and transparency across teams.
“Uncountable is a highly flexible and configurable system, backed by an excellent support team that is collaborative and responsive. The platform’s flexibility makes it easier for researchers to relate to and adopt,” said Ja Kim, Global R&D IT Leader, Digital Solutions at Qnity.
“By combining integrated systems with structured, high-quality data that power analytics and AI/ML-driven insights, we help companies like Qnity accelerate product development and bring innovations to market faster. Qnity is a premier technology provider in the semiconductor value chain that is powering the modern world, and we are proud to be their partner” said Noel Hollingsworth, CEO of Uncountable.
About Qnity
Qnity is an independent electronics materials company focused on enabling advanced semiconductor and electronics manufacturing. The company delivers innovative materials, technologies, and solutions that help customers drive performance, sustainability, and scale across next-generation applications.
About Uncountable
Uncountable is the AI platform for end-to-end product development. It captures, structures, and connects data across the lifecycle to create a unified data layer powering AI-driven innovation, productivity, and risk reduction. Uncountable operates globally, serving more than 150 customers across chemicals, advanced materials, consumer goods, food and agriculture, and pharmaceuticals.
